129 related articles for article (PubMed ID: 32228259)
1. Investigation of the effects of vatinoxan on somatic and visceral antinociceptive efficacy of medetomidine in dogs.
Huuskonen V; Restitutti F; Honkavaara JM; Raekallio MR; Männikkö S; Scheinin M; Vainio OM
Am J Vet Res; 2020 Apr; 81(4):299-308. PubMed ID: 32228259
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and sedation reversal effects of intramuscular administration of atipamezole in dogs treated with medetomidine hydrochloride with or without the peripheral α
Turunen H; Raekallio MR; Honkavaara JM; Restitutti F; Kallio-Kujala IJ; Adam M; Nevanperä K; Scheinin M; Männikkö SK; Hautajärvi HJ; Larenza Menzies P; Vainio OM
Am J Vet Res; 2019 Oct; 80(10):912-922. PubMed ID: 31556714
[TBL] [Abstract][Full Text] [Related]
3. Effects of intramuscular vatinoxan (MK-467), co-administered with medetomidine and butorphanol, on cardiopulmonary and anaesthetic effects of intravenous ketamine in dogs.
Turunen H; Raekallio M; Honkavaara J; Jaakkola J; Scheinin M; Männikkö S; Hautajärvi H; Bennett R; Vainio O
Vet Anaesth Analg; 2020 Sep; 47(5):604-613. PubMed ID: 32682664
[TBL] [Abstract][Full Text] [Related]
4. Sedative effect of intramuscular medetomidine with and without vatinoxan (MK-467), and its reversal with atipamezole in sheep.
Adam M; Raekallio MR; Vainio OM
Vet Anaesth Analg; 2018 Nov; 45(6):788-793. PubMed ID: 30301665
[TBL] [Abstract][Full Text] [Related]
5. Effects of vatinoxan on cardiorespiratory function and gastrointestinal motility during constant-rate medetomidine infusion in standing horses.
Tapio H; Raekallio MR; Mykkänen A; Männikkö S; Scheinin M; Bennett RC; Vainio O
Equine Vet J; 2019 Sep; 51(5):646-652. PubMed ID: 30793362
[TBL] [Abstract][Full Text] [Related]
6. Comparison between dexmedetomidine and a combination of medetomidine-vatinoxan on muscle tissue saturation in privately-owned adult dogs undergoing intradermal testing.
McKenzie SR; Chiavaccini L; Moura RA; Santoro D
Res Vet Sci; 2024 May; 171():105207. PubMed ID: 38460204
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of medetomidine enantiomers and vatinoxan, an α
Honkavaara JM; Raekallio MR; Syrja PM; Pypendop BH; Knych HK; Kallio-Kujala IJ; Vainio OM
Vet Anaesth Analg; 2020 Jan; 47(1):47-52. PubMed ID: 31761600
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of premedication with medetomidine alone and in combination with MK-467 or glycopyrrolate in dogs subsequently anesthetized with isoflurane.
Salla KM; Tuns CI; Bennett RC; Raekallio MR; Scheinin M; Kuusela E; Vainio OM
Am J Vet Res; 2017 Nov; 78(11):1245-1254. PubMed ID: 29076369
[TBL] [Abstract][Full Text] [Related]
9. Effects of MK-467 on the antinociceptive and sedative actions and pharmacokinetics of medetomidine in dogs.
Bennett RC; Salla KM; Raekallio MR; Hänninen L; Rinne VM; Scheinin M; Vainio OM
J Vet Pharmacol Ther; 2016 Aug; 39(4):336-43. PubMed ID: 26763145
[TBL] [Abstract][Full Text] [Related]
10. Effects of vatinoxan on cardiorespiratory function, fecal output and plasma drug concentrations in horses anesthetized with isoflurane and infusion of medetomidine.
Tapio HA; Raekallio MR; Mykkänen AK; Al-Ramahi D; Scheinin M; Hautajärvi HJ; Männikkö S; Vainio O
Vet J; 2019 Sep; 251():105345. PubMed ID: 31492389
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha
Restitutti F; Kaartinen MJ; Raekallio MR; Wejberg O; Mikkola E; Del Castillo JRE; Scheinin M; Vainio OM
Vet Anaesth Analg; 2017 May; 44(3):417-426. PubMed ID: 28552594
[TBL] [Abstract][Full Text] [Related]
12. The impact of vatinoxan on medetomidine-ketamine-midazolam immobilization in Patagonian maras (Dolichotis patagonum).
Greunz EM; Limón D; Petersen RL; Raekallio MR; Grøndahl C; Bertelsen MF
Vet Anaesth Analg; 2021 May; 48(3):372-379. PubMed ID: 33820746
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of intravenous vatinoxan in wild boars (Sus scrofa) anaesthetised with intramuscular medetomidine-tiletamine-zolazepam.
Einwaller J; Meyer LCR; Auer U; Raekallio M; Nowack J; Haw A; Vetter S; Painer J; Stalder G
Vet Rec; 2022 Jan; 190(2):e835. PubMed ID: 34472117
[TBL] [Abstract][Full Text] [Related]
14. Effects of vatinoxan in rats sedated with a combination of medetomidine, midazolam and fentanyl.
Lindh E; Meller A; Raekallio M
Acta Vet Scand; 2024 May; 66(1):23. PubMed ID: 38822394
[TBL] [Abstract][Full Text] [Related]
15. Effects of vatinoxan in dogs premedicated with medetomidine and butorphanol followed by sevoflurane anaesthesia: a randomized clinical study.
Salla KM; Turunen HA; Kallio-Kujala IJ; Pekkola V; Casoni DC; Lepajoe J; Björkenheim P; Raekallio MR; Vainio O
Vet Anaesth Analg; 2022 Nov; 49(6):563-571. PubMed ID: 36115767
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the sedative and clinical effects of xylazine, detomidine, medetomidine and dexmedetomidine in miniature donkeys.
Samimi AS
N Z Vet J; 2020 May; 68(3):198-202. PubMed ID: 31778611
[No Abstract] [Full Text] [Related]
17. Cardiovascular effects of intravenous vatinoxan (MK-467) in medetomidine-tiletamine-zolazepam anaesthetised red deer (Cervus elaphus).
Einwaller J; Painer J; Raekallio M; Gasch K; Restitutti F; Auer U; Stalder GL
Vet Anaesth Analg; 2020 Jul; 47(4):518-527. PubMed ID: 32507716
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cardiovascular effects of intramuscular medetomidine and a medetomidine-vatinoxan combination in Beagle dogs: A randomized blinded crossover laboratory study.
Joerger FB; Wieser ML; Steblaj B; Niemann L; Turunen H; Kutter AP
Vet Anaesth Analg; 2023 Sep; 50(5):397-407. PubMed ID: 37481386
[TBL] [Abstract][Full Text] [Related]
19. The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol.
Salla K; Restitutti F; Vainionpää M; Junnila J; Honkavaara J; Kuusela E; Raekallio M; Vainio O
Vet Anaesth Analg; 2014 Nov; 41(6):567-74. PubMed ID: 24674053
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary and sedative effects of the peripheral α2-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogs.
Rolfe NG; Kerr CL; McDonell WN
Am J Vet Res; 2012 May; 73(5):587-94. PubMed ID: 22533388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
